These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 23529734

  • 1. Pharmacokinetic evaluation of the interaction between hepatitis C virus protease inhibitor boceprevir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and pravastatin.
    Hulskotte EG, Feng HP, Xuan F, Gupta S, van Zutven MG, O'Mara E, Wagner JA, Butterton JR.
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2582-8. PubMed ID: 23529734
    [Abstract] [Full Text] [Related]

  • 2. Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin.
    Mazzu AL, Lasseter KC, Shamblen EC, Agarwal V, Lettieri J, Sundaresen P.
    Clin Pharmacol Ther; 2000 Oct; 68(4):391-400. PubMed ID: 11061579
    [Abstract] [Full Text] [Related]

  • 3. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors.
    Jacobson TA.
    Am J Cardiol; 2004 Nov 01; 94(9):1140-6. PubMed ID: 15518608
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin.
    Lilja JJ, Kivistö KT, Neuvonen PJ.
    Clin Pharmacol Ther; 1999 Aug 01; 66(2):118-27. PubMed ID: 10460065
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy volunteers.
    Bullman J, Nicholls A, Van Landingham K, Fleck R, Vuong A, Miller J, Alexander S, Messenheimer J.
    Epilepsia; 2011 Jul 01; 52(7):1351-8. PubMed ID: 21635243
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic interactions between the hepatitis C virus protease inhibitor boceprevir and ritonavir-boosted HIV-1 protease inhibitors atazanavir, darunavir, and lopinavir.
    Hulskotte EG, Feng HP, Xuan F, van Zutven MG, Treitel MA, Hughes EA, O'Mara E, Youngberg SP, Wagner JA, Butterton JR.
    Clin Infect Dis; 2013 Mar 01; 56(5):718-26. PubMed ID: 23155151
    [Abstract] [Full Text] [Related]

  • 14. Lack of clinically significant pharmacokinetic interaction between the thrombopoietin receptor agonist eltrombopag and hepatitis C virus protease inhibitors boceprevir and telaprevir.
    Wire MB, Fang L, Hussaini A, Kleha JF, Theodore D.
    Antimicrob Agents Chemother; 2014 Nov 01; 58(11):6704-9. PubMed ID: 25155600
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of itraconazole on the pharmacokinetics of atorvastatin.
    Kantola T, Kivistö KT, Neuvonen PJ.
    Clin Pharmacol Ther; 1998 Jul 01; 64(1):58-65. PubMed ID: 9695720
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Coadministration of dabigatran etexilate and atorvastatin: assessment of potential impact on pharmacokinetics and pharmacodynamics.
    Stangier J, Rathgen K, Stähle H, Reseski K, Körnicke T, Roth W.
    Am J Cardiovasc Drugs; 2009 Jul 01; 9(1):59-68. PubMed ID: 19178132
    [Abstract] [Full Text] [Related]

  • 19. The interaction of diltiazem with lovastatin and pravastatin.
    Azie NE, Brater DC, Becker PA, Jones DR, Hall SD.
    Clin Pharmacol Ther; 1998 Oct 01; 64(4):369-77. PubMed ID: 9797793
    [Abstract] [Full Text] [Related]

  • 20. Single-dose pharmacokinetics of boceprevir in subjects with impaired hepatic or renal function.
    Treitel M, Marbury T, Preston RA, Triantafyllou I, Feely W, O'Mara E, Kasserra C, Gupta S, Hughes EA.
    Clin Pharmacokinet; 2012 Sep 01; 51(9):619-28. PubMed ID: 22799589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.